Literature DB >> 26076850

Counting seizures: The primary outcome measure in epileptology from the patients' perspective.

Barbara Blachut1, Christian Hoppe2, Rainer Surges1, Jutta Stahl3, Christian E Elger1, Christoph Helmstaedter1.   

Abstract

PURPOSE: Patient-reported seizure counts represent a key outcome measure for individual treatments and clinical studies in epileptology. Video-EEG based research, however, demonstrated lack of validity due to underreporting. Here we examined the practice of keeping seizure diaries and the patients' attitudes toward seizure counting.
METHODS: Anticipating a low return rate, a comprehensive survey was mailed to 1100 adult outpatients. Besides methods and reasons to document or not to document seizures, the questionnaire addressed clinical, personality and sociodemographic characteristics as well as the subjective experience of seizures.
RESULTS: Questionnaires from 170 patients (15%) could be included in our analysis. Patients estimated to be aware of 5.3 out of 10 daytime seizures (nocturnal seizures: 2.6) while they supposed that relatives/colleagues noticed 7.1 (nocturnal: 4.6). Almost two-thirds of the patients reported to keep a seizure diary with a self-estimated documentation rate of 8.7 out of 10 noticed daytime seizures (nocturnal: 7.7). Documenters and non-documenters showed only marginal group differences with regard to clinical, personality and sociodemographic characteristics. Importantly, patients were more committed to keep a seizure diary when they judged it to be relevant for clinical treatment decisions.
CONCLUSION: Patients appear to know that they underreport seizures. According to their view, seizure unawareness as induced by seizures themselves seems to be a more important factor than omitting documentation of noticed seizures. Thus, the potential to improve the validity of seizure diaries of electronic devices which facilitate documenting noticed seizures appears limited.
Copyright © 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Epilepsy; Patient-reported outcome measure; Seizure diary; Seizure frequency

Mesh:

Year:  2015        PMID: 26076850     DOI: 10.1016/j.seizure.2015.03.004

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  6 in total

1.  Detection of Generalized Tonic-Clonic Seizures in Dogs With a Seizure Detection System Established Using Acceleration Data and the Mahalanobis Distance: A Preliminary Study.

Authors:  Junya Hirashima; Miyoko Saito; Tsukasa Kuriyama; Taketo Akamatsu; Minoru Yokomori
Journal:  Front Vet Sci       Date:  2022-04-28

Review 2.  Serotonin and sudden unexpected death in epilepsy.

Authors:  Alexandra N Petrucci; Katelyn G Joyal; Benton S Purnell; Gordon F Buchanan
Journal:  Exp Neurol       Date:  2019-12-19       Impact factor: 5.330

3.  Early detection rate changes from a brain-responsive neurostimulation system predict efficacy of newly added antiseizure drugs.

Authors:  Imran H Quraishi; Michael R Mercier; Tara L Skarpaas; Lawrence J Hirsch
Journal:  Epilepsia       Date:  2019-12-17       Impact factor: 5.864

Review 4.  Embedding digital chronotherapy into bioelectronic medicines.

Authors:  John E Fleming; Vaclav Kremen; Ro'ee Gilron; Nicholas M Gregg; Mayela Zamora; Derk-Jan Dijk; Philip A Starr; Gregory A Worrell; Simon Little; Timothy J Denison
Journal:  iScience       Date:  2022-03-04

5.  Developing a Conceptual Disease Model of Patient Experiences and Identifying Patient-Reported Clinical Outcome Assessments for Use in Trials of Treatments for Focal Onset Seizures.

Authors:  Dorothee Oberdhan; Elizabeth Bacci; Jennifer N Hill; Andrew Palsgrove; Asha Hareendran
Journal:  Neuropsychiatr Dis Treat       Date:  2022-03-22       Impact factor: 2.570

Review 6.  Current norms and practices in using a seizure diary for managing epilepsy: A scoping review.

Authors:  Chika K Egenasi; Anandan A Moodley; Wilhelm J Steinberg; Anthonio O Adefuye
Journal:  S Afr Fam Pract (2004)       Date:  2022-09-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.